- 2022 - 2025 セロトニンシグナルを標的とした扁平上皮癌分化誘導療法の開発
- 2022 - 2025 Actionable遺伝子変異に基づく新たな口腔扁平上皮癌治療戦略の開発
- 2020 - 2023 PDXモデルを用いたCD44v陽性口腔がん幹細胞の特性評価と新規薬剤治療の確立
- 2019 - 2022 標準治療抵抗性口腔扁平上皮癌における標的可能遺伝子変異の同定と個別化治療の確立
- 2016 - 2019 Development of novel treatment targeting cancer stromal cells in standard treatment-resistant oral squamous cell carcinoma
- 2016 - 2019 Analysis of metabolic changes associated with cetuximab resistance in oral squamous cell carcinoma and designing of new treatment
- 2014 - 2017 Development of the therapy for cetuximab-resistant oral squamous cell carcinoma cells
- 2013 - 2016 Treatment sensitivity evaluation of oral squamous cell carcinoma based on the expression of a functional cancer stem cell marker CD44v
- 2010 - 2012 New classification of oral squamous cell carcinoma based on the molecular expression profile controlling the epithelial mesenchymal transition and stem cell-like characteristics
Show all